Literature DB >> 31279012

Early-stage myeloid-derived suppressor cell count: Basophil exclusion matters.

Fabrice Uhel1, Imane Azzaoui2, Simon Le Gallou2, Thierry Fest2, Karin Tarte2, Mikael Roussel3.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 31279012     DOI： 10.1016/j.jaci.2019.06.027

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  4 in total

Review 1.  CD123-Directed Bispecific Antibodies for Targeting MDS Clones and Immunosuppressive Myeloid-Derived Suppressor Cells (MDSC) in High-Risk Adult MDS Patients.

Authors:  Fatih M Uckun; Justin Watts
Journal:  Front Aging       Date:  2021-09-27

2.  Circulating Myeloid Regulatory Cells: Promising Biomarkers in B-Cell Lymphomas.

Authors:  Juliette Ferrant; Faustine Lhomme; Simon Le Gallou; Jonathan M Irish; Mikael Roussel
Journal:  Front Immunol       Date:  2021-02-02       Impact factor: 7.561

3.  Quantification of Early-Stage Myeloid-Derived Suppressor Cells in Cancer Requires Excluding Basophils.

Authors:  Anm Nazmul H Khan; Tiffany R Emmons; Jerry T Wong; Emad Alqassim; Kelly L Singel; Jaron Mark; Brandon E Smith; Joseph D Tario; Kevin H Eng; Kirsten B Moysich; Kunle Odunsi; Scott I Abrams; Brahm H Segal
Journal:  Cancer Immunol Res       Date:  2020-04-01       Impact factor: 12.020

4.  Circulating and tumor-infiltrating arginase 1-expressing cells in gastric adenocarcinoma patients were mainly immature and monocytic Myeloid-derived suppressor cells.

Authors:  WeiHong Ren; XuRan Zhang; WenBo Li; Qian Feng; HuiJie Feng; Yan Tong; Hao Rong; Wei Wang; Dai Zhang; ZhenQiang Zhang; ShiChun Tu
Journal:  Sci Rep       Date:  2020-05-15       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.